Identification of p53 unbound to T-antigen in human cells transformed by simian virus 40 T-antigen

Oncogene

Volumn 14, Issue 8, 1997, Pages 955-965

  O'Neill, F J ^a,b   Hu, Y ^a   Chen, T ^a   Carney, H ^b  

^a UNIVERSITY OF UTAH   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Human cells; Immortalization; p53; T antigen; Transformation

Indexed keywords

PROTEIN P53; VIRUS T ANTIGEN;

ARTICLE; CELL CLONE; CELL IMMORTALIZATION; COMPLEX FORMATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; SIMIAN VIRUS 40; TEMPERATURE SENSITIVE MUTANT; VIRUS CELL TRANSFORMATION;

EID: 0030978259     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1200913     Document Type: Article

References (60)

1. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K. (Eds). (1987). Current Protocols in Molecular Biology. Ariene Publishing, A. Wiley-Interscience: New York.
2. Bartek J, Iggo R, Cannon J and Lane DP. (1990). Oncogene, 5, 893-899.
3. Benchimol S, Pine D and Crawford L. (1982). EMBO. J., 1, 1053-1062.
4. Carroll RB and Gurney EG. (1982). J. Virol., 44, 565-573.
5. Chen C and Okayama H. (1987). Mol. Cell. Biol., 7, 2745-2752.
6. Crawford LV. (1983). Internat. Rev. Exp. Pathol., 25, 1-50.
7. Deppert W. (1994). Elsevier Science BV, Amsterdam.
8. Deppert W and Haug M. (1986). Mol. Cell. Biol., 6, 2233-2240.
9. Deppert W. (1994). Semin. Cancer. Biol., 5, 187-202.
10. Deppert W. (1989). NATO ASI Series, Springer-Verlag, Berlin.
11. Deppert W, Haug M and Steinmayer T. (1987). Mol. Cell Biol. 7, 4453-4463.
12. Donehower LA and Bradley A. (1993). Biophysica. Acta, 1155, 181-205.
13. Farmer G, Bargonetti J, Zhu H, Friedman P, Prywes R and Prives C. (1992). Nature, 358, 83-86
14. Fritsche M, Haessler C and Brandner G. (1993). Oncogene, 8, 307-318.
15. Fukasawa K, Sakoulas G, Pollock RE and Chen SA. (1991). Mol. Cell. Biol., 11, 3472-3483.
16. Gannon JV, Greaves R, Iggo R and Lane DP. (1990). EMBO J., 9, 1595-1602.
17. Gee AP and Langone JJ. (1981). Anal. Biochem. 116, 524-530.
18. Gurney E, Harrison O and Fenno J. (1980). J. Virol., 34, 752-763.
19. Haggerty S, Walker DL and Frisque RJ. (1989). J. Virol., 63, 2180-2190.
20. Hansen R, Reddel R and Braithwaite A. (1995). Oncogene, 11, 2535-2545.
21. Hollstein M, Sidransky D, Vogelstein B and Harris CC. (1991). Science, 253, 49-53.
22. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B and Craig RW. (1991). Cancer Res., 51, 6304-6311.
23. Kierstead TD and Tevethia MJ. (1993). J. Virol., 67, 1817-1829.
24. Kraiss S, Quaiser A, Oren M and Montenahr M. (1988). J. Virol., 62, 4737-4744.
25. Lane DP. (1992). Nature (London) 358, 15-16.
26. Lane DP and Benchimol S. (1990). Genes Dev. 4, 1-8.
27. Lane DP and Crawford LV. (1980). Proc. R. Soc. Lond. 210, 451-463.
28. Lane DP and Crawford LV. (1979). Nature (London), 278, 261-263.
29. Levine AJ, Momand J and Finlay CA. (1991). Nature, 351, 453-456.
30. Lin J-Y and Simmons DT. (1991b). J. Virol., 65, 6447-6453.
31. Lin J-Y and Simmons DT. (1990). Virology, 176, 302-305.
32. Linzer DIH and Levine AJ. (1979). Cell, 17, 43-52.
33. Maltzman W and Czyzyk L. (1984). Mol. Cell. Biol., 4, 1689-1694.
34. Meek DW. (1994). Cancer Biology, 5, 203-210.
35. Mercer WE, Avignolo C and Baserga R. (1984). Mol. Cell Biol., 4, 276-281.
36. Michael-Michalovitz D, Yehiely F, Gottlieb E and Oren M. (1991). J. Virol., 65, 4160-4168.
37. Michalovitz D, Eliyahu D and Oren M. (1986). Mol. Cell Biol., 6, 3531-3536.
38. Moore M, Teresky AK, Levine AJ and Seiberg M. (1992). J. Virol., 66, 641-649.
39. O'Neill FJ, Frisque RJ, Xu X, Hu Y and Carney H. (1995). Oncogene, 90, 1131-1139.
40. O'Neill FJ, Xu X, Gao Y, Rosenfeld M, Jenkins F and Carney H. (1994). Virus Res., 34, 237-263.
41. O'Neill FJ, Gao Y and Xu X. (1993). Virus Res., 30, 171-178.
42. O'Neill FJ, Xu X and Gao Y. (1992). Virus Res., 25, 169-187.
43. O'Neill FJ, Xu XL and Miller TH. (1990). Intervirology, 31, 175-187.
44. O'Neill FJ, Renzetti L, Miller TH and Stevens R. (1988). Virus Res., 11, 109-125.
45. O'Neill FJ, Maryon EB and Carroll D. (1982). J. Virol., 43, 18-25.
46. Prives C, Bargonetti J, Friedman PN, Manfredi JJ and Wang EH. (1991). Cold Spring Harbor Symp. Quant. Biol., 56, 227-235.
47. Southern PJ and Berg P. (1982). J. Mol. Appl. Genet., 1, 327-341.
48. Tegtmeyer P. (1975). J. Virol., 15, 613-618.
49. Tiemann F and Deppert W. (1994a). J. Virol., 68, 2869-2878.
50. Tiemann F and Deppert W. (1994b). Oncogene, 9, 1907-1915.
51. Tiemann F, Zerrahn J and Deppert W. (1995). J. Virol., 69, 6115-6121.
52. Ullrich SJ, Mercer WE and Appella E. (1992). Oncogene, 7, 1635-1643.
53. van den Heuvel SJL, The SI, Klein B, Jochemsen AG, Zantema A and van der Eb AJ. (1992). J. Virol., 66, 591-595.
54. Vojtesek B, Bartek J, Midgley CA and Lane DP. (1992). J. Immunol. Methods, 151, 237-244.
55. Werness BA, Levine AJ and Howley PM. (1990). Science, 248, 76-79.
56. Whyte P, Williamson NM and Harlow E. (1989). Cell, 56, 67-75.
57. Yolken RH and Leister FJ. (1981). J. Immunol. Methods, 54, 209-218.
58. Zerrahn J and Deppert W. (1993). J. Virol., 67, 1555-1563.
59. Zakut-Houri R, Bienz-Tadmor B, Gival D and Oren M. (1985). EMBO J., 4, 1251-1255.
60. Zhu Y, Abate M, Rice P and Cole CN. (1991). J. Virol., 65, 6872-6880.